1.Extrapulmonary tuberculosis (ET)
Journal of Medical and Pharmaceutical Information 2001;1():2-5
Some peculiarities on clinical features of ET in Vietnam are described concerning favorable conditions of the disease referred to the forms of ET and the age ranges, the patient's gender. Diagnostic means of ET are listed. The association of at least 2 clinical syndromes is noticed. Recommendations are made for treatment and management of ET in the framework of the National tuberculosis prevention and control Program.
Tuberculosis
;
diagnosis
2.Anti-tuberculosis - drugs - related hepatitis
Journal of Medical and Pharmaceutical Information 2003;0(3):5-11
Most of anti-tuberculosis drugs are hepatic toxicity; especially 3 most common and best efficient drugs R, H, Z. Drug combination resulted in increasing toxicity, adverse events, especially drug-induced hepatitis. The authors reviewed situation of drug-induced hepatitis in the world and introduced one case in Vietnam. He also listed some drug known that have hepatotoxicity such as isoniazid (INH, H); rifampicin (RMP, R); pyrazinamid (PZA, Z); ethambutol (EMB, E); ethionamid (ETB); thiacetazon (TH, Tbl) and their mechanisms. Some experiences in treating and preventing drug-induced hepatitis were introduced
Tuberculosis
;
Hepatitis, Chronic, Drug-Induced
;
Tuberculosis, Multidrug-Resistant
;
drugs
3.The role of bronchodilators drug in the treatment of COPD
Journal of Medical and Pharmaceutical Information 2004;0(9):8-12
Chronical obstructive pulmonary disease (COPD), bronchus asthma and pneumonia are 3 common causes of death. Among them COPD is the leading cause of morbidity and mortality in Europa, the 4th leading cause in North America. Currently, there are 3 main groups of largely used medicaments beta 2 agonist, anticholin and methylxxanthin. With diverse pharmacological characteristics, all 3 groups also dilate the bronchus, change the diameter of air channel and the dilative pressure of the lung. They impact on the respiratory tract by 2 mechanisms: directly on the smooth muscle cell of the tract and inhibite the bronchus contraction neurologically. The mechanism and the level of their effects are differented in the treatment of bronchus asthma and COPD, in depending on each subject
Pulmonary Disease, Chronic Obstructive
;
Therapeutics
;
Bronchodilator Agents